慢性炎症性脱叶林性多神经病的皮下免疫球蛋白:一个历史的视角
Dario Cocito1, Erdita Peci1, Maria Claudia Torrieri2
1Clinical and Biological Sciences Department, University of Turin, 10043 Orbassano, Italy.
Journal of clinical medicine
|November 25, 2023
概括
皮下免疫球蛋白 (SCIg) 与静脉注射免疫球蛋白 (IVIg) 在慢性炎症性脱髓化多神经病 (CIDP) 中同样有效. SCIg为患者提供更好的耐受性,方便性和生活质量.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性炎症性脱髓化多神经病 (CIDP) 是一种衰弱的神经系统疾病.
- 静脉注射免疫球蛋白 (IVIg) 是一种常见的治疗方法,但它存在管理方面的挑战.
- 皮下免疫球蛋白 (SCIg) 提供了另一种治疗途径.
研究的目的:
- 审查和比较SCIg与IVIg在CIDP治疗中的疗效和使用情况.
- 突出SCIg的优势,包括患者的耐受性和方便性.
- 讨论在CIDP中支持SCIg的演变和临床证据.
主要方法:
- 在CIDP中对SCIg和IVIg的现有临床研究进行叙述性审查.
- 治疗有效性,耐受性和施用方法的比较.
- 分析患者的生活质量和成本效益.
主要成果:
- 在治疗CIDP方面,SCIg的疗效与IVIg相当.
- SCIg更好地耐受,更容易管理 (不需要输液接入),并且更方便.
- 通过在家进行灵活的治疗安排,SCIg提高了患者的生活质量.
- 高度的IgG溶液和新型器件有助于有效的SCIg管理.
结论:
- SCIg是对CIDP的成熟和有利的治疗方法,得到了PATH等研究的支持.
- SCIg提供了一个以患者为中心的IVIg替代品,增强治疗坚持和治疗结果.
- 进一步的研究和技术进步继续优化SCIg治疗CIDP.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Inflammatory Bowel Disease IV: Pharmacological Management
130
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
130


